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Prolyl aminodipeptidase (PepX) is an enzyme that hydrolyzes peptide bonds
from the N-terminus of substrates when the penultimate amino-acid residue is a
proline. Prolyl peptidases are of particular interest owing to their ability to
hydrolyze food allergens that contain a high percentage of proline residues.
PepX from Lactobacillus helveticus was cloned and expressed in Escherichia coli
as an N-terminally His-tagged recombinant construct and was crystallized by
hanging-drop vapor diffusion in a phosphate buffer using PEG 3350 as a
precipitant. The structure was determined at 2.0 Å resolution by molecular
replacement using the structure of PepX from Lactococcus lactis (PDB entry
1lns) as the starting model. Notable differences between the L. helveticus PepX
structure and PDB entry 1lns include a cysteine instead of a phenylalanine at the
substrate-binding site in the position which confers exopeptidase activity and
the presence of a calcium ion coordinated by a calcium-binding motif with the
consensus sequence DX(DN)XDG.

1. Introduction
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Aminopeptidases are of interest in the food industry for the
production of protein hydrolysates, which are more easily
digested, have an altered texture or taste, display improved
antioxidant properties and have a reduced presence of
common food allergens. The X-prolyl dipeptidyl aminopeptidase (PepX) from Lactobacillus helveticus is a 92 kDa peptidase which speciﬁcally hydrolyzes a peptide bond C-terminal
to a penultimate proline residue at the N-terminus of a
peptide. To date, the only known structure of a bacterial PepX
enzyme is that from Lactococcus lactis (Rigolet et al., 2002).
L. lactis PepX has 34% sequence identity to the L. helveticus
enzyme and >50% sequence similarity (Altschul et al., 1990).
L. helveticus PepX is known to form dimeric assemblies
through noncovalent interactions (Vesanto et al., 1995) and
the L. lactis structure was found to be a homodimer with
twofold rotation symmetry, in which each monomer contains a
single active site within an / -hydrolase fold (Rigolet et al.,
2005).
L. helveticus is a lactic acid-fermenting bacterium that is
commonly used in the fermentation of milk for commercial
cheese production. It is known to be effective in breaking
down potentially allergenic milk proteins which contain a high
content of proline residues. A recombinant L. helveticus PepX
enzyme, both alone and in combination with PEPN (a general
aminopeptidase), has been shown to improve the antioxidant
effect of casein hydrosylates as well as to decrease the
https://doi.org/10.1107/S2053230X19011774
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Table 1
Cloning and expression of PepX.
Source organism
DNA source
Forward primer†

L. helveticus
Leeners helveticus cheese starter culture
TCATTCACATCATATGAAATATAACCAATA
TGCTTACG
TCACATCTCGAGTTATTTTTCATAAAACTT
GATTTCAGT

Reverse primer‡
Cloning/expression vector
Expression host
Complete amino-acid sequence
of the construct produced§

Novagen pET-14b
E. coli BL21(DE3)pLysS
MGSSHHHHHHSSGLVPRGSHMKYNQYAYVE
TDFQQQVKELIDINFLPKNYQVWDFGSL
LAKLVKNAIAEAKTDAAKNAKLAEFAVS
DHQTLADFLKEKPTEIGTKQFYNVALQL
LGYHVHYDYDFADPTGFMQRNALPFLQD
ISDNQKLISAFYRLLNTRAKNGQILLDV
MAGKGYFTQFWGQNKFKFFNGKSIPVFD
TNKVIREVVYVETDLDTDHDGKSDLIQV
TVFRPEETNKGLKVPALYTASPYFGGII
ANEKRNHNVDENLSDSTEWNDPQYVHSP
IVKAEKPDGSSRPATEEAVHKSSYPLNE
YMLARGFASVFAGAIGTRGSDGVRITGA
PEETESAAAVIEWLHGDRVAYTDRTRTV
RTTADWCNGNIGMTGRSYLGTLQIAIAT
TGVKGLKTVVSEAAISSWYDYYREHGSV
IAPEACQGEDLDLLAETCQSNLWDAGSY
LKIKPEYDKMQKQLREKEDRNTGQYSDF
WEAGNYRHHADGIKCSWISVHGLNDWNV
KPKNVYKIWQLVKKMPMKHHLFLHQGPH
YNMNNLVSIDFTDLMNLWFVHELLGIEN
NAYNQWPTVMIQDNLQADKWHEEPDWSN
DLGQEKIYYPTDEGELFQDGNGKAQKSF
TDVGGIEFKKAGISESDWQYKFICGDEK
WAKPSLRFETDEFTHPTTIVGRPEVKVR
VSASLPKGEISVALVELGERQRLTATPK
FLMHGGQELGYRFGTDTLQEFVPDKKTK
AKLITKAHMNLQNFKDMKKPEAIDADKF
YDLDFLLQPTYYTIPSGSKLALIIYSTD
QGMTKRPLEDETYTIDLANTEIKFYEK

† The forward primer contains an NdeI restriction site. ‡ The reverse primer contains
an XhoI restriction site. § The amino-acid sequence includes a 20-residue N-terminal
afﬁnity tag prior to the ﬁrst residue of the PepX sequence.

bitterness typically caused by large hydrophobic peptides that
contain a high percentage of prolines (Stressler et al., 2013,
2016).
Peptidases from lactobacilli, as well as fungal or other
bacteria-derived prolyl endopeptidases (PEPs), have been
suggested for use in the enzymatic detoxiﬁcation of gluten, a
food allergen found in wheat, rye and barley that is toxic to
people with celiac disease (CD; Caputo et al., 2010; Wieser &
Koehler, 2012). Reports of CD patients being able to tolerate
sourdough breads better than other gluten-containing breads
could possibly be owing to the activity of lactobacilli peptidases (Gerez et al., 2008). The gliadin and glutenin proteins
found in gluten, like milk proteins, also contain a high
percentage of proline residues that are not easily digested by
our own gastric and pancreatic enzymes. For example, a CD
immunogenic 33-mer peptide from 2-gliadin has been shown
to persist in both in vivo and in vitro assays against intestinal
peptidases (Shan et al., 2002). Lactobacilli-extracted peptidases, including PepX, have shown promise in detoxifying
gluten peptides (Gerez et al., 2008; De Angelis et al., 2010;
Francavilla et al., 2017; Gallo et al., 2005); however, they are
not particularly active or stable at low pH and are also
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susceptible to other digestive proteases. Regardless of these
known limitations, it has been suggested that PepX in
combination with PEPN and possibly PEPO (a neutral
endopeptidase) would be sufﬁcient to completely detoxify
gluten (De Angelis et al., 2010; Gallo et al., 2005).
Here, we report the crystal structure of the L. helveticus
PepX enzyme at 2.0 Å resolution as well as the activity of the
recombinant enzyme on a gluten peptide.

2. Materials and methods
2.1. Cloning, expression and purification

The pepx gene was PCR-ampliﬁed from an L. helveticus
cheese starter culture (Leeners). The identity of the bacterial
isolates grown on MRS plates was conﬁrmed at the species
level by 16S rRNA gene sequencing using universal 8F and
1492R primers (SeqWright). The gene was ampliﬁed with
forward and reverse primers (Invitrogen) containing NdeI and
XhoI restriction sites (Table 1). The pepx gene was ligated into
a pET-14b expression vector to attach an N-terminal histidine
tag and placed into an Escherichia coli BL21(DE3)pLysS cell
line (Novagen). The pepx gene was sequenced (SeqWright)
and the translated protein sequence was found to be a 99%
match to NCBI reference sequence WP_003629197.1, with the
following four amino-acid variations: S36G, Q347R, L401S
and R462G. E. coli cultures were grown at 37 C in LB-Miller
broth until they reached an OD600 of between 0.5 and 1.0, and
protein expression was induced by the addition of 0.8 mM
IPTG. The cultures were grown for an additional 4 h at room
temperature and the cells were harvested by centrifugation.
The PepX protein was puriﬁed using procedures that were
slightly modiﬁed from those reported previously (Vesanto et
al., 1995; Stressler et al., 2013). The cells were resuspended in
20 mM Tris buffer pH 8.0, 1 mM EDTA pH 8.0, 0.5 mg ml1
lysozyme and were allowed to incubate on ice with stirring for
1 h. The lysate was doubled in volume with water and brought
to 0.25 U ml1 DNAse I (New England Biolabs), 5 mg ml1
pancreatic RNAse A (Sigma), 1 mM MgCl2, 0.1 mM CaCl2.
The lysate was stirred at room temperature for 30 min and
then sonicated. The cell debris was removed by centrifugation
and the soluble lysate was fractionated by ammonium sulfate
precipitation (30 and 80% saturation). PepX found in the 80%
fractionated pellet was resuspended and dialyzed in 50 mM
potassium phosphate buffer pH 6.5. PepX was puriﬁed by
chromatography using a Nickel HiTrap IMAC Sepharose FF
column (GE Healthcare Life Sciences) with a running buffer
consisting of 50 mM potassium phosphate pH 6.5, 20 mM
imidazole, 500 mM NaCl, eluting with a linear gradient to
500 mM imidazole. Fractions containing PepX as determined
by SDS–PAGE were combined, dialyzed into 50 mM potassium phosphate buffer pH 6.5 and further puriﬁed by HiTrap
Q FF anion-exchange chromatography (GE Healthcare Life
Sciences) using a running buffer consisiting of 50 mM Tris pH
7.2 and eluting with a linear gradient to 1.0 M NaCl. Fractions
containing PepX were combined and dialyzed into 50 mM
potassium phosphate buffer pH 6.5.

Prolyl aminodipeptidase
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Table 2

Table 3

Crystallization.

Data collection and processing.

Method
Plate type

Values in parentheses are for the outer shell.

Hanging-drop vapor diffusion
VDXm plate with siliconized glass cover
slides (Hampton Research)
Temperature (K)
296
1
Protein concentration (mg ml ) 4–7
Buffer composition of protein 50 mM potassium phosphate buffer pH 6.5
solution
Composition of reservoir
75 mM potassium phosphate buffer pH 6.0,
solution
1 mM DTT, 6.8–7.2% PEG 3350
Volume and ratio of drop
5 ml; 1:1 and 1:5
Volume of reservoir (ml)
1

2.2. Crystallization

The PepX used for crystallization was concentrated to
between 4 and 7 mg ml1 using Corning Spin-X UF Concentrators (10 000 molecular-weight cutoff). Rhomboid-shaped
crystals formed after 1–2 weeks of growth, with the largest
crystals ranging between 200 and 300 mm in size (Table 2).
2.3. Crystal mounting, X-ray data collection, processing and
refinement

The crystals were manipulated under a humid air ﬂow
(95% relative humidity; Farley et al., 2014). The crystals were
ﬁrst mounted at room temperature (295 K) in MicroRT tubes
(MiTeGen, Ithaca, New York, USA) using nylon loops
(Hampton Research, Aliso Viejo, California, USA) or
micromeshes (MiTeGen). A small amount (20 ml) of the
crystal well solution was added to the MicroRT tube before
mounting. The PepX crystals diffracted with visible spots to
4 Å resolution at room temperature and unit-cell parameters
could be determined, but the diffraction did not last very long
(1 h). Low-temperature diffraction was therefore pursued.
Crystals were mounted in a cold nitrogen-gas stream (Cryojet,
Oxford Instruments, Abingdon, England; 100 K sample/shield
ﬂows at 6/4 l min1, respectively) using the vial-mounting
approach (Farley et al., 2014). Crystals were tested with (listed
with decreasing levels of thermal contraction) methanol,
2-methyl-2,4-pentanediol, ethylene glycol, glycerol and xylose
as cryoprotective agents (Alcorn & Juers, 2010). Of these, the
best results were observed with 30–40% ethylene glycol;
however, the diffraction was weak. Consequently, a highly
redundant data set was collected at 100 K to improve the
accuracy of the high-resolution data. For the data set reported
here, a cover slip containing PepX crystals was transferred to a
humidity-controlled stage for crystal manipulation. A PepX
crystal (180  200  300 mm) was transferred from the cover
slip to an 20 ml drop of solution consisting of synthetic
mother liquor [7%(w/v) PEG 3350, 75 mM potassium phosphate pH 6.0] supplemented with 40%(v/v) ethylene glycol for
30 s. The crystal was mounted with a nylon loop and transferred to a vial containing 500 ml of the cryosolution for
transfer to the cold gas stream. The crystal was simultaneously
mounted in the gas stream as the vial was removed.
X-ray data were collected using an Oxford Diffraction Nova
X-ray source (50 kV/0.8 mA) and an Oxford Diffraction Onyx
CCD detector. Bragg diffraction spots were visible to 3.0 Å
Acta Cryst. (2019). F75, 625–633

Diffraction source

Oxford Diffraction Nova
sealed-tube micro-focus
1.54056
100
Oxford Diffraction Onyx CCD
85.0
0.3
604.8
60
P43212
154.63, 154.63, 106.59
90, 90, 90
1.02
30.33–2.00 (2.04–2.00)
1599555 (45905)
87344 (4411)
100.0 (100.0)
18.3 (10.4)
8.1 (0.5)†
0.40 (4.95)
0.99 (0.25)
21.4

Wavelength (Å)
Temperature (K)
Detector
Crystal-to-detector distance (mm)
Rotation range per image ( )
Total rotation range ( )
Exposure time per image (s)
Space group
a, b, c (Å)
, , ( )
Mosaicity ( )
Resolution range (Å)
Total No. of reﬂections
No. of unique reﬂections
Completeness (%)
Multiplicity
hI/(I)i
Rmeas
CC1/2
Overall B factor from Wilson plot (Å2)

† CC1/2 was used to determine the resolution cutoff. hI/(I)i falls below 2.0 at 2.57 Å
resolution.

resolution, so a data-collection strategy was created with 2.0 Å
as a target resolution using CrysAlisPro (Oxford Diffraction).
Data were integrated and scaled in CrysAlisPro and were
merged with AIMLESS (Evans, 2006) and CTRUNCATE
(French & Wilson, 1978; Winn et al., 2011). Using the criterion
of CC1/2 = 0.25, a resolution limit of 2.0 Å was chosen (Table 3;
Karplus & Diederichs, 2015).
Although the data set was highly redundant, the anomalous
signal was weak. Consequently, the structure was solved using
molecular replacement with Phaser in PHENIX (McCoy et al.,
2007; Adams et al., 2010) with PDB entry 1lns as a starting
model (Rigolet et al., 2002). This is an X-prolyl dipeptidyl
aminopeptidase from L. lactis with 34% amino-acid identity to
PepX. The molecular-replacement solution was then used as
input to AutoSol in PHENIX. In this case, because the
sequence identity between the search model and the target
structure was low, rather than rebuilding the search model,
AutoBuild in PHENIX built the target structure from scratch
using as input the amino-acid sequence (NCBI reference
amino-acid sequence WP_003629197.1; PepX from L. helveticus) and the output map from Phaser density-modiﬁed
with RESOLVE (Terwilliger, 2003). The autobuilt structure
was then inspected residue by residue using Fo  Fc, 2Fo  Fc
and, in places of ambiguity, OMIT electron density. After a few
cycles of reﬁnement in PHENIX and model building in Coot
(Emsley et al., 2010), the four amino-acid changes identiﬁed
above were conﬁrmed in the electron-density maps. Sample
electron density is shown in Supplementary Fig. S1. Additional rounds of reﬁnement and model building, including the
addition of solvent molecules, resulted in a ﬁnal model
containing 794 amino-acid residues, water molecules, ethylene
glycol molecules, a calcium ion and four phosphate ions. The
protein chain includes all 793 residues of the cloned sequence
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as well as one of 20 extra N-terminal residues (which include a
six-His tag for puriﬁcation). The remaining 19 residues are not
visible in the electron-density map, and appear to occupy a
relatively large solvent channel in the crystal (Table 4). The
coordinates and structure factors have been deposited in the
Protein Data Bank with code 6nff.
2.4. Activity assays

The Michaelis constant (Km) for puriﬁed PepX at 1 nM was
measured using varying concentrations of the dipeptide
substrate mimic Gly-Pro-p-nitroanilide hydrochloride (GPpNA;
Sigma) in 50 mM MES buffer pH 6.5 and monitoring the
change in absorption at 410 nm over time at 40 C. Successive
dipeptidase activity was monitored by digestion of the
octamer peptide FPQPQLPY (Biomatik), with PepX at
100 nM and octamer peptide at 1 mg ml1 in 0.1 M Tris pH 8.0
at room temperature (23  1 C). Time points were taken at 0,
10, 45 and 120 min and were analyzed by RP-HPLC (Restek,
C18, 5 mm, 100  4.6 mm). The peptides eluted during a linear
gradient from 5 to 30% acetonitrile (in water and 0.1% TFA)
at a ﬂow rate of 1 ml min1 over 20 min.

3.1. Overall structure of PepX from L. helveticus

The structure of PepX from L. lactis (PDB entry 1lns) is the
prototype of the S15 peptidase family of the SC clan (Rigolet
et al., 2002). The structure of PepX from L. helveticus (PDB
entry 6nff) is the second structure determined for this clan and
family of serine peptidases. The crystal structure was determined at 2.0 Å resolution (Tables 3 and 4) and PDB entry 6nff
exhibits a four-domain structure with an overall shape that
resembles the continent of Africa, as initially pointed out by
Rigolet et al. (2002) (Fig. 1). For the structure with PDB code
1lns, the crystals were also grown with PEG (4000) as precipitant at pH 5.2 and the X-ray data were collected at 298 K.
The catalytic domain of PDB entry 6nff (residues 183–388
and 463–573) contains a canonical / -hydrolase fold (Carr &
Ollis, 2009). It consists of a ten-stranded -sheet (1, 2, 4, 3, 5, 6,
7, 8, 9 and 10) in which strands 2 and 10 are antiparallel to the
rest (Fig. 2). Helices intervene between all strands, except
between strands 1 and 2 and between strands 9 and 10, to give
a total of ten helical structures (A, A0 , A00 , B, C, D, E, F, G and
G0 ). The conserved catalytic triad (Ser363, Asp483 and
His514) is located N-terminal to helix D, within the loop
between -strand 7 and helix F and the loop between -strand
8 and helix G. The catalytic domain also contains a long loop
that is described as a ‘lasso’ loop by Rigolet et al. (2002) in the
structure with PDB code 1lns and is unique among / hydrolase folds. This loop (residues 228–286) is located
between -strand 3 and helix B and surrounds the smaller
helical domain while also making contacts with the C-terminal
domain. Although PDB entries 6nff and 1lns both exhibit the
same ten-stranded -sheet pattern, there are several differences in the secondary-structural elements that connect the
strands. For example, strands 2 and 3 are connected by a helix
Ojennus et al.



Structure solution and reﬁnement.
Values in parentheses are for the outer shell.
Resolution range (Å)
Completeness (%)
No. of reﬂections, working set
No. of reﬂections, test set
Final Rcryst
Final Rfree
Estimated coordinate error (Å)
No. of non-H atoms
Total
Protein
Ion (Ca2+, phosphate)
Ligand (ethylene glycol)
Water
R.m.s. deviations
Bonds (Å)
Angles ( )
Average B factors (Å2)
Overall
Protein
Ion (Ca2+, phosphate)
Ligand (ethylene glycol)
Water
Ramachandran plot†
Most favored (%)
Allowed (%)

30.33–2.00 (2.02–2.00)
97.6 (94.0)
80812 (2541)
4332 (130)
0.236 (0.476)
0.273 (0.447)
0.35
7050
6400
21
68
561
0.008
1.2
34
34
43
38
36
96.0
3.8

† The Ramachandran plot was produced with MolProbity (Chen et al., 2010)

3. Results and discussion

628

Table 4

in PDB entry 6nff but not in PDB entry 1lns. A connecting
helix between strands 2 and 3 is not part of the typical eightstranded canonical / -hydrolase fold, but is occasionally
observed in / -hydrolases (Carr & Ollis, 2009) such as plant
carboxylesterases (Ileperuma et al., 2007). Also, a small
additional -sheet structure, which also deviates from the
canonical fold, is observed in the regions between strands 4
and 5 of PDB entry 1lns but is absent in PDB entry 6nff.
The two amino-acid Ramachandran outliers reported in
Table 4 (using MolProbity) are located at positions Ala304
and Pro513. Two additional outliers, as reported by DeepView/
Swiss-PdbViewer (Guex & Peitsch, 1997), are His100 and
Ser363. The electron density for these four residues is unambiguous. His100 is rather far from the active site, but appears
to be involved in the dimer contact. Ala304, Ser363 and
Pro513 are all in the catalytic domain. Ser363 is the catalytic
nucleophile, while Pro513 immediately precedes the catalytic
histidine in the amino-acid sequence. Steric strain is frequently
observed at the catalytic serine in / -hydrolases to form the
‘nucleophile elbow’ and oxyanion hole (Carr & Ollis, 2009).
Here, we see that steric strain may also be required to
correctly position the residue neighboring the catalytic histidine. Dimitriou and coworkers described a ‘catalytic acid
zone’ for / -hydrolases (Dimitriou et al., 2017, 2019) that is
necessary for proper coordination of the catalytic histidine
within the catalytic triad. Of the seven representatives of
group A catalytic acid zone structures that they analyzed
across six protein families, the equivalent histidine neighboring position is found to have higher backbone energy strain
than the catalytic histidine in all but one structure (Supplementary Table S1). The histidine neighbor in three of the
seven structures falls into an allowed, although not favored,

Prolyl aminodipeptidase

electronic reprint

Acta Cryst. (2019). F75, 625–633

research communications

Figure 1
Three-dimensional structure (PDB entry 6nff) of L. helveticus PepX (a) shown with the N-terminal domain in red, the C-terminal domain in yellow, the
helical domain in green and the / -hydrolase domain in cyan. The active-site residues located in the catalytic domain are shown as spheres in CPK
colors and a bound calcium ion, also located within the catalytic domain, is shown as a magenta sphere. The ‘lasso loop’ (residues 228–286) of the
catalytic domain is shown in dark blue and the extended loop of the C-terminal domain (672–710) is shown in orange. (b) Structure of the dimer observed
in the crystal looking down a twofold rotational crystal symmetry axis. The dimer shown is supported as biologically relevant by calculations with PISA,
suggesting the burial of 4250 Å2 at the shown interface and a dissociation free energy of 9.1 kcal mol1 (Krissinel & Henrick, 2007). (c) The calciumbinding motif located between 1 and 2 of the catalytic domain. The calcium ion exhibits octahedral coordination with Asp194 (2.4 Å), Asp196 (2.3 Å),
Asp198 (2.5 Å), Asp202 (2.4 Å), the carbonyl of Lys200 (2.3 Å) and a water molecule, HOH1137 (2.3 Å). The water molecule also appears to be within
hydrogen-bonding distance of Asp198 and the backbone carbonyl of Ser201 (not shown). This ﬁgure was prepared with PyMOL (Schrödinger).

region of the Ramachandran plot (using DeepView): Asp234
in hydroxynitrilase (PDB entry 3c6x), Asp237 in salicylic acidbinding protein 2 (PDB entry 1xkl) and Gly555 in acylaminoacid-releasing enzyme (PDB entry 2hu5) (Dimitriou et al.,
2017; Schmidt et al., 2008; Forouhar et al., 2005; Kiss et al.,
2007).
The helical domain (residues 389–462) is between strand 6
and helix E of the catalytic domain and makes substantial
contacts with it. Cap domains involved in substrate binding are
not uncommon in / -hydrolase folds (Carr & Ollis, 2009).
It consists of ﬁve helices (three -helices and two 310-helices)
and provides important contacts at the substrate-binding site
that are proposed to position the substrate and confer
exopeptidase activity (Supplementary Table S2; Rigolet et al.,
2002, 2005). The helical domain also makes contact with the
C-terminal domain and is surrounded by the ‘lasso’ loop of the
catalytic domain.
The N-terminal domain of PDB entry 6nff (residues 1–182)
consists of a bundle of eight -helices very similar to the
domain found in PDB entry 1lns. At the time that the structure
with PDB code 1lns was published (Rigolet et al., 2002), no
structural homology was observed to anything else in the PDB
for the N-terminal domain, and this continues to be the case
Acta Cryst. (2019). F75, 625–633

for PDB entry 6nff. SCOPe lists the N-terminal PepX domain
as its own family and superfamily (a.40.2 and a.40.2.1; Murzin
et al., 1995; Fox et al., 2014). This superfamily is one of three
identiﬁed as containing a CH-like domain protein fold among
the all- -helical protein domain class. The N-terminal domain
was proposed to be responsible for the dimerization of PDB
entry 1lns owing to extensive contacts between monomers,
and this is also observed in our structure (Fig. 1; Rigolet et al.,
2002). The crystal dimer is likely to be physiologically relevant, as dimerization of L. helveticus PepX in solution has
been observed and reported previously (Vesanto et al., 1995).
The C-terminal domain (residues 574–793) highly resembles
the SCOPe galactose-binding domain-like superfamily, with a
twisted -sandwich structure (Murzin et al., 1995; Fox et al.,
2014). Three structurally homologous domains are known in
the PepX C-terminal domain-like family (b.18.13): -aminoacid ester hydrolase from Acetobacter pasteurianus and
Xanthomonas citri, the C-terminal domain of bacterial cocaine
esterase from Rhodococcus sp. MB1 and the PepX C-terminal
domain from L. lactis. The C-terminal domain of PDB entry
6nff also contains an unusual long loop (residues 672–710) that
wraps around the catalytic domain, as was also observed for
PDB entry 1lns (Fig. 1; Rigolet et al., 2002).
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Figure 2
Secondary-structural map as assigned by STRIDE (Heinig & Frishman,
2004) for the / -hydrolase domain of L. helveticus PepX (a) compared
with L. lactis PepX (b).

TM-align (Zhang & Skolnick, 2005) was used to align the
structures with PDB codes 1lns and 6nff and reported an
aligned length of 755 residues with an overall r.m.s.d. of 2.4 Å
for C atoms. The normalized TM-score was 0.94, which
strongly indicates high structural similarity. Regions of divergence in the structures of the PDB entries 6nff and 1lns
primarily occur within the loops between secondary structures.
However, three major regions of divergence, in which more
than ten sequential amino acids diverge by 2 Å or more, are
observed within the ‘lasso loop’, the second and third helices
of the N-terminal domain and the ﬁrst two strands and helices
of the C-terminal domain (Supplementary Fig. S2).

helix between strands 2 and 3 while PDB entry 1lns does not.
PDB entry 1lns also has an additional small -sheet structure
between strands 4 and 5, while PDB entry 6nff does not (Fig. 2
and Supplementary Fig. S3). Despite these differences, the
residues at the substrate-binding site are strictly conserved
and superimpose well (Fig. 3 and Supplementary Table S2).
The only signiﬁcant difference between the two structures
in the active-site region is the residue corresponding to
Cys408, which is a phenylalanine (Phe393) in PDB entry 1lns
(and a glutamate, Glu205, in PDB entry 1r9n). This residue
was postulated by Rigolet et al. (2005) to be responsible for
exopeptidase activity in PepX by interacting with the
N-terminus of the substrate, similar to Glu205 in DPP-IV,
where the glutamate can hydrogen-bond to the N-terminus
and, along with a second glutamate, block the entry of the
substrate any further into the interior of the protein. As a
consequence, only the second peptide bond of the substrate is
positioned for nucleophilic attack by the catalytic serine,
conferring exopeptidase activity rather than endopeptidase
activity. This amino-acid difference may explain the differences in speciﬁcities for dipeptide substrate mimics that have
been reported based on the identity of the N-terminal amino
acid (Stressler et al., 2013; Degraeve & Martial-Gros, 2003;
Zevaco et al., 1990). PepX from L. lactis hydrolyzes the
dipeptide substrate mimic RPpNA (116% relative activity;
Zevaco et al., 1990) faster than APpNA (100% relative
activity), while PepX from L. helveticus has been reported to
hydrolyze APpNA faster (100% relative activity) than
RPpNA (70.7 and 59% relative activity; Stressler et al., 2013;
Degraeve & Martial-Gros, 2003). Although the structural
reason for this selectivity is not clear, the difference in relative
activities does not appear to be a question of steric hindrance
when considering that arginine paired with phenylalanine is
more favorable than alanine as the N-terminal residue in the
substrate. This suggests a favorable cation– interaction in
PDB entry 1lns that is absent in PDB entry 6nff. However,
when looking at the interactions between binding-site residues
and the YPSK peptide in the DPP-IV structure (PDB entry
1r9n; Aertgeerts et al., 2004), this position (Glu205 in PDB
entry 1r9n, Phe393 in PDB entry 1lns and Cys408 in PDB
entry 6nff) appears to interact solely with the amide backbone
of the N-terminal residue and not the side chain (Fig. 3).

3.2. Substrate-binding site

The substrate-binding site is found at residues surrounding
the catalytic triad (Ser363, Asp483 and His514) within the
catalytic domain as well as neighboring residues in the helical
domain (Supplementary Table S2). Although no structure is
available of any PepX bound to substrate, the binding site is
nearly identical to human dipeptidyl peptidase-4 (DPP-IV), a
functional homolog for which a structure bound to substrate is
known (PDB entry 1r9n; Rigolet et al., 2005; Aertgeerts et al.,
2004). Thus, parallels can be drawn to describe the PepX
binding site (Rigolet et al., 2005).
Few differences exist between the catalytic and helical
domains of PDB entries 6nff and 1lns. The number of strands
in the central -sheet is the same, but PDB entry 6nff has a
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3.3. Calcium-binding site

Another signiﬁcant difference between the structures with
PDB codes 6nff and 1lns is the presence of a calcium-binding
site (Figs. 1 and 2). The amino-acid sequence of L. helveticus
contains a DX(DN)XDG consensus sequence for a calciumbinding motif (Supplementary Fig. S3; Rigden et al., 2011).
Unlike the canonical EF-hand structure, in which this
consensus sequence occurs in a loop between two -helices
(Kawasaki et al., 1998; Gifford et al., 2007), the structure with
PDB code 6nff shows this sequence occurring in a loop
between two -strands (strands 1 and 2; see Figs. 1 and 2) of
the catalytic domain. This structure most closely resembles a
calcium blade, a term coined by Rigden and coworkers, who

Prolyl aminodipeptidase
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Figure 3
(a) Superposition of the active/binding-site residues between L. helveticus PepX (PDB entry 6nff, cyan) and PepX from L. lactis (PDB entry 1lns,
orange). Binding-site residues are conserved, with the exception of Cys408, which is a phenylalanine (Phe393) in PDB entry 1lns. Labels are for the
residues in PDB entry 6nff. The alignment was performed in PyMOL (Schrödinger) using the super utility, which reported an r.m.s.d. of 1.4 Å for 3848
aligned atoms after ﬁve cycles of reﬁnement. (b) Model of L. helveticus PepX (cyan) bound to the YPSK peptide (green). The model was produced by
aligning the active/binding sites of PDB entries 1r9n and 6nff in PyMOL (Schrödinger) and then transferring the bioactive peptide from the structure
with PDB code 1r9n to that with PDB code 6nff. The resulting complex was solvated in an octahedral water box using CHARMM-GUI (Jo et al., 2008;
Brooks et al., 2009; Lee et al., 2016), and NAMD (Phillips et al., 2005) scripts were generated. The model was energy-equilibrated using NAMD with the
CHARMM36m force ﬁeld (Huang & MacKerell, 2013) at 310.15 K. The resulting model was obtained after step four of the CHARMM-GUI-generated
NAMD equilibration script, which ran 25 000 energy-minimization steps.

identiﬁed several examples of calcium-binding motifs across
many different fold families all containing the DX(DN)XDG
consensus sequence in a strand–loop–strand conﬁguration, of
which several occurred in -propeller proteins (Rigden et al.,
2011; Rigden & Galperin, 2004). Denesyuk et al. (2017) later
deﬁned a structural motif called the calcium-blade zone which
describes the necessary interactions between the motif and the
calcium ion beyond the three aspartic acid residues of the
consensus sequence and identiﬁed how a calcium-blade zone
differs from an EF-hand zone even though they may both
contain the DX(DN)XDG consensus sequence.
The calcium-binding blade-like site identiﬁed in PDB entry
6nff matches the consensus sequence of a calcium-blade zone
with ten amino acids that form the closed loop: LDTDHDGKSD (residues 193–202). The calcium is coordinated in a
distorted octahedral shape by the side chains of Asp194,
Asp196 and Asp198 in the ﬁrst, second and third coordination
positions. The fourth coordination position is occupied by the
backbone carbonyl of Lys200 and the ﬁfth position by the side
chain of Asp202. The sixth coordination position is occupied
by a water molecule that is also within hydrogen-bonding
distance of the second O atom in the side chain of Asp198
(2.0 Å) and the backbone carbonyl of Ser201 (2.3 Å). This
calcium-blade zone most closely resembles those identiﬁed in
the seven- and eight-stranded -propeller folds of integrin
-IIb (PDB entry 3t3p) and rhamnogalacturonan lyase (PDB
entry 2zux) (Denesyuk et al., 2017; Zhu et al., 2012; Ochiai et
al., 2009). To our knowledge, this is the ﬁrst calcium-binding
protein from the SCOP superfamily and with the / -hydrolase fold (SCOPe c.69 and c.69.1) that contains a calciumblade zone sequence and a calcium-binding blade-like site,
Acta Cryst. (2019). F75, 625–633

increasing the number of identiﬁed distinct folds containing
this motif from 12 to 13 (Denesyuk et al., 2017).
Although EF-hands and their roles in calcium regulation
in eukaryotes have been well documented, calcium-binding
proteins (CaBPs) and their roles in bacteria have yet to be
fully explored (Michiels et al., 2002; Domı́nguez et al., 2015).
The role of calcium in the L. helveticus PepX structure, if one
exists, is not known. A possibility is that it exists only to confer
stability to the / -hydrolase fold, as has been suggested for
some other bacterial proteins that contain the DX(DN)XDG
loop sequence (Rigden et al., 2011; Suzuki et al., 2009; Li et al.,
2010; Cioci et al., 2006). Alternatively, it could be involved in
the regulation of PepX activity. It has previously been documented that the activity of the L. helveticus PepX enzyme
displays metal dependence, although not necessarily with
respect to calcium. The enzyme is still fully active at EDTA
concentrations of 1–10 mM, but is strongly inhibited in the
presence of other divalent metals such as copper, cadmium,
zinc, iron and mercury (Vesanto et al., 1995; Stressler et al.,
2013). If these metals also interact with the calcium-binding
blade-like site, inhibition is likely to result owing to distortion
of the active/binding site (calcium is coordinated by residues
found in the catalytic domain and is located 27 Å from the
catalytic serine). Since PepX activity does not appear to rely
on the presence of calcium, it is worth investigating whether
calcium confers any structural stability or enables proper
folding.
3.4. Activity of PepX Against an immunogenic octamer

The activity of the recombinant construct of L. helveticus
PepX used for crystallization was tested against a GPpNA
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regulatory role for metal binding that needs further investigation. Finally, it is worth noting that many commercially
available digestive aids, such as the over-the-counter supplements Gluten-Zyme and GlutenEase, frequently contain
probiotic blends that include L. helveticus or the DPP-IV
enzyme. Although the effectiveness of these digestive aids has
not been fully evaluated for the treatment of gluten intolerance and celiac disease, lactobacilli peptidases such as
L. helveticus PepX continue to be an area of interest for
enzyme-detoxiﬁcation strategies.

5. Related literature

Figure 4
Hydrolysis of a gluten octamer peptide by L. helveticus PepX monitored
over time by RP-HPLC. The octamer (FPQPQLPY) elutes at 1022 s, the
hexamer (QPQLPY) at 820 s and the tetramer (QLPY) at 760 s. The
identities of the eluted peptides were conﬁrmed by LC-MS (data not
shown).

substrate mimic. The Km was determined to be between 250
and 310 mM (data not shown), which is in good agreement
with the Km of 240 mM reported by Degraeve & Martial-Gros
(2003) for the same substrate. To examine the effectiveness of
PepX against gluten-derived peptides with a high proline
content, the activity of the enzyme was monitored over time
with an octamer peptide substrate (FPQPQLPY) that is found
within a celiac disease immunogenic 33-mer -gliadin peptide
(LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF) identiﬁed as persisting under digestive conditions (Shan et al.,
2002). The sequence within the 33-mer was selected to include
two XPXP repeats as well as an XXP motif which should not
be recognized by PepX. A digest with 100 nM PepX and
1 mg ml1 substrate showed nearly complete hydrolysis to
liberate the ﬁrst FP dipeptide within 10 min (Fig. 4). The
second QP dipeptide was mostly liberated by 45 min, and after
2 h only the tetramer (QLPY) remained. Although hydrolysis
of the second dipeptide appeared to lag behind that of the ﬁrst
dipeptide, this provides good evidence that PepX is capable of
hydrolyzing peptides with XP repeats, which are frequently
found within gluten protein sequences. PepX, when used in
combination with one or two additional lactobacilli digestive
enzymes, may be sufﬁcient to completely detoxify gluten
peptides, as suggested previously (De Angelis et al., 2010;
Gallo et al., 2005).

4. Conclusion
The structure of L. helveticus PepX provides a second example
from the S15 peptidase family of the SC clan. Although the
structures are very similar, a single amino-acid difference at
the substrate-binding site may explain the differences in
substrate speciﬁcity that have been observed for L. helveticus
PepX compared with L. lactis PepX. Also, the DX(DN)XDG
calcium-binding site that is present in L. helveticus PepX but
is absent in L. lactis PepX suggests a unique structural or
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